ライフサイエンスコーパス: m-

1 m) for 30 mg of neladenoson group; and 13.0 m (95% CI, -5.9 to 31.9 m) for 40 mg of neladenoson grou

2 or placebo-treated patients (difference 13.0 m [SE 10.4], 95% CI -7.4 to 33.4; p=0.213).

3 urs after a final study beverage and by 18.0 m ([90% CI, -1.7 to +infinity] P=0.12) at 24 hours after

4 d mean change in 6MWD from baseline was -2.0 m (68.1) for the pirfenidone group and -26.7 m (79.3) fo

5 Pilot field tests were performed at 3.0 m (shallow test) and 7.9 m (deep test) below ground surf

6 walk test increased with allo-hMSCs by 37.0 m (p = 0.04), but not auto-hMSCs at 7.3 m (p = 0.71; aut

7 BFRRE improved 6-minute walk test by 39.0 m (CI, 7.0-71.1, P=0.019) compared with control.

8 ncy, with measured plate counts of 1,650,000/m +/- 7%, corresponding to a reduced plate height of h =

9 mean velocity was less than or equal to 4.06 m .sec(-1) at axial SWE (sensitivity, 54.2%; 95% confide

10 difference in change from baseline of 35.09 m (95% CI 7.59 to 62.60; p=0.014) versus placebo.

11 ges in 6-minute walk test distance were 58.1 m (95% CI, 26.1-90.1) and 41.4 m (95% CI, 8.2-74.5), res

12 gered when evidence of erosion is within 6.1 m ("20 ft") of certain structures, allowing an applicant

13 ed measurements of equivalent dose rate at 1 m (EDR-1m) from the sternum and urinary bladder were obt

14 At sulfate concentrations greater than 1 m (molal), bidentate sulfate is observed, a coordination

15 i) the reduced monoanions [Ru2-C2m-Ru2](-1) (m = 4-8) belong to the Robin-Day class II mixed valent i

16 all living within a radius of <300 or <1000 m (14% or 58% population) would target 30% or 66% of inf

17 For each 1000-m (3300-ft) increase in altitude above 2500 m (8200 ft),

18 out any deficits (26%) had worse 6MWD = -109 m (95% confidence interval [CI], -175 to -43), London Ch

19 es were similar: upslope shifts averaged 113 m (Mt.

20 ced aortic CoQ [22 d (35+/-8.4%; P<0.05); 12 m (53+/-8.8%; P<0.05)], accelerated aortic telomere shor

21 Karimui) and 123 m (Karkar Island) for lower limits.

22 (2005-2008) for persons living less than 150 m (versus more than 300 m) from major roadways, adjustin

23 Karimui) and 152 m (Karkar Island) for upper limits and 95 m (Mt.

24 Our results suggest that a 16 m *O. megalodon likely had a head ~ 4.65 m long, a dorsa

25 tance (399 vs 417 m; absolute difference, 18 m [95% CI, 6-30]; P = .30), after adjustment for age, se

26 line in 6-minute walk test distance were 0.2 m (95% CI, -12.1 to 12.4 m) for the placebo group; 19.4

27 >) ) and AO incorporation (up to 12 % at 0.2 m [AO]) are appreciable.

28 The 1 - 2 m (~3 - 6 ft) rule of spatial separation is central to d

29 the available data do not support the 1 - 2 m (~3 - 6 ft) rule of spatial separation.

30 ce, eight showed droplets travel more than 2 m (~6 ft), in some cases more than 8 meters (~26 ft).

31 large droplets do not travel further than 2 m (~6 ft).

32 s-Fe(CO)3(P((CH2)mCH horizontal lineCH2)3)2 (m = a/4; b/5, c/6, e/8) and Grubbs' catalyst (12-24 mol

33 ty risk was high with AVA/height <0.45 cm(2)/m (adjusted HR, 2.18 [1.28-3.71]), followed by AVA/BSA <

34 ], 3.42 [2.09-5.60]), AVA/height <0.45 cm(2)/m (adjusted HR, 3.99 [2.42-6.60]), AVA/weight <0.01 cm(2

35 itochondrial calcium concentration ([Ca(2+) ]m ) was measured at different stimulation frequencies (0

36 eneral formula [Ru(n)(tda)(py)2](m+) (n = 2, m = 0, 1; n = 3, m = 1, 2(+); n = 4, m = 2, 3(2+)), with

37 29)O(102))(4)} (M = Mn, Co, Ni or Zn, n = 2, m = 4; M = Cu, n = 3, m = 5) (5-9).

38 ter samples collected at depths less than 20 m (adjusted R(2) values greater than 0.80) and in soil s

39 Modeled deep water concentrations below 200 m (5-15 pg/L) were slightly higher than measurements (<5

40 (95% CI, -4 m to infinity) (P = .06) and +21 m (95% CI, -5 m to infinity) (P = .12) for 6-minute walk

41 d expiratory volume in the first second, +21 m (95% CI, -4 m to infinity) (P = .06) and +21 m (95% CI

42 ed nanometer-femtosecond resolution (10(-21) m . s).

43 lood heights increased by approximately 1.24 m (due mainly to sea level rise) from approximately A.D.

44 6 min walk test distance (from a mean of 244 m [SD 112] to 318 m [134]; p=0.016).

45 ted amputation walked on a treadmill at 1.25 m . s(-1).

46 Median 6MWT improvement was 25 m (IQR, 19-47 m).

47 -m (3300-ft) increase in altitude above 2500 m (8200 ft), AMS prevalence increased 13% (95% CI, 9.5%-

48 2.27 to 19.47), improvement in 6MWT of 43.28 m (31.36 to 55.21), and reduction in the SGRQ of 9.39 po

49 (95% CI: 0.75 to 1.39) for 6MW distance <288 m (bottom tertile).

50 m(-2)), and total global SOC in the top 0.3 m (822 Pg C) accurately.

51 oundwater levels and indicate a 17.9 +/- 1.3 m (+/-1 SE) decline in water-table depth in Southern Cal

52 duction in the 6-minute walk distance (-11.3 m [95% CI, -31.7 to 9.7] versus 25.3 m [95% CI, 6.1-44.5

53 29.8 m) for 20 mg of neladenoson group; 16.3 m (95% CI, -1.1 to 33.6 m) for 30 mg of neladenoson grou

54 p = 0.001) for the younger and 35.9 +/- 18.3 m (p = 0.038) for the older participants (p = NS between

55 (-11.3 m [95% CI, -31.7 to 9.7] versus 25.3 m [95% CI, 6.1-44.5]; P=0.01), an increase in QRS durati

56 e than exercise alone (mean difference, -6.3 m [95% CI, -30.2 to +17.6]; P = .61) or more than GM-CSF

57 37.0 m (p = 0.04), but not auto-hMSCs at 7.3 m (p = 0.71; auto vs. allo p = 0.0168).

58 pping the intervention the effect waned (7.3 m [95% CI -32.5 to 47.0]; p=0.50).

59 u(n)(tda)(py)2](m+) (n = 2, m = 0, 1; n = 3, m = 1, 2(+); n = 4, m = 2, 3(2+)), with tda(2-) being [2

60 , Co, Ni or Zn, n = 2, m = 4; M = Cu, n = 3, m = 5) (5-9).

61 UO2Ac2(H2O)n(MeOH)(m)H(+) (n = 1, 2, 3,...; m = 1, 2, 3,...).

62 s) fields at subfield resolutions of 30 x 30 m (0.09 ha) across 30 million ha of 10 Midwest states.

63 mpaction air samples were taken not </=0.305 m (1 foot), 0.914 m (3 feet), and 1.829 m (6 feet) from

64 Baseline preprocedural 6MWT distance was 308 m (interquartile range [IQR], 234-394 m).

65 from non-labouring sea level (n = 3) or 3100 m (n = 3) women.

66 stance (from a mean of 244 m [SD 112] to 318 m [134]; p=0.016).

67 significantly reduced in the Sherpa at 3400 m (-30.3 +/- 21.6%; P < 0.01) and 4371 m (-14.2 +/- 10.7

68 re than 25% of individuals ascending to 3500 m (11500 ft) and more than 50% of those above 6000 m (19

69 l (CI) 297-581], 466 m (99% CI 359-574), 353 m (99% CI 210-496), and 403 m (99% CI 58-749), respectiv

70 al [CI]: 0.26 to 0.66) for 6MW distance >386 m (top tertile); HR: 0.57 (95% CI: 0.39 to 0.83) for 6MW

71 I: 0.39 to 0.83) for 6MW distance 288 to 386 m (middle tertile); and HR: 1.02 (95% CI: 0.75 to 1.39)

72 ion control + placebo (mean difference, -1.4 m [95% CI, -25.2 to +22.4]; P = .91).

73 -12.1 to 12.4 m) for the placebo group; 19.4 m (95% CI, -10.8 to 49.7 m) for the 5 mg of neladenoson

74 7 m) for the 5 mg of neladenoson group; 29.4 m (95% CI, 3.0 to 55.8 m) for 10 mg of neladenoson group

75 16.1 to 6.8) for losmapimod 7.5 mg, and -3.4 m (-15.1 to 8.2) for losmapimod 15 mg.

76 12.3-33.3 degrees C) and median depth of 4.4 m (IQR = 19 m; range = 0-452 m).

77 nce were 58.1 m (95% CI, 26.1-90.1) and 41.4 m (95% CI, 8.2-74.5), respectively; the placebo-adjusted

78 ond, 95% CI: -0.14, -0.08; and betawalking 4 m = -0.08 m/second, 95% CI: -0.10, -0.06).

79 formula (PA)(2m+4)(MA)(m-2)Pb(2m+1)I(7m+4) (m = 2, 3, 4).

80 omides with the general formula A(m)MnBr(4) [m = 1 or 2, A = dimethylammonium (DMA), 3-methylpiperidi

81 (n = 2, m = 0, 1; n = 3, m = 1, 2(+); n = 4, m = 2, 3(2+)), with tda(2-) being [2,2':6',2''-terpyridi

82 CI 359-574), 353 m (99% CI 210-496), and 403 m (99% CI 58-749), respectively (P = 0.40).

83 terval: 1.05, 1.28) than those who lived 416 m (75th percentile) away.

84 3400 m (-30.3 +/- 21.6%; P < 0.01) and 4371 m (-14.2 +/- 10.7%; P = 0.03).

85 imal walking distance after 6 months was 439 m [99% confidence interval (CI) 297-581], 466 m (99% CI

86 [99% confidence interval (CI) 297-581], 466 m (99% CI 359-574), 353 m (99% CI 210-496), and 403 m (9

87 e walking distance increased from 390 to 467 m (P = .02) 5 months after PEA.

88 een the tadalafil and placebo groups was 0.5 m (95% CI -11.6 to 12.5; p=0.937).

89 At week 25, mean 6MWD had increased by 31.5 m (SE 9.8) from baseline for continuous drisapersen, wit

90 with a mean 6-minute walk distance of 384.5 m (SD 103.9).

91 -mg/d vericiguat and placebo groups was -5.5 m (95% CI, -19.7 m to 8.8 m; P = .45) and between the 10

92 f 300 m or more to less than 400 m, and -9.5 m (17.2, -43.2 to 24.2; p=0.580) in the group with a 6MW

93 00 m(-2) within a depth range of 1,100 1,500 m (overall observed depth range 841-2,266 m).

94 elevations to a precision better than +/-500 m (1sigma).

95 )=82+/-4%) and following 3 to 6 days at 5050 m (high altitude; Spo(2)=83+/-3%).

96 [SE 10.3]) and placebo (mean difference 3.51 m [-24.34 to 31.35]) at week 25.

97 on emission tomography, gait speed over 4.57 m (15 ft), and cognition on the Mini-Mental State Examin

98 68.5, 81.7) and less than or equal to 14.58 m .sec(-1) at sagittal SWE (sensitivity, 58.3%; 95% CI:

99 After PR 6MWD increased by 56 +/- 58 m (P < 0.001), the physical summary component of SF36 (0

100 Participants who lived 58 m (25th percentile) from major roadways had lower LPR (b

101 are, with a between-group difference of 14.6 m (Hodges-Lehmann 97.5% CI, 0.4 m to infinity; 1-sided P

102 year post-TESI in both groups: 48.5 +/- 14.6 m (p = 0.001) for the younger and 35.9 +/- 18.3 m (p = 0

103 on control + placebo (mean difference, +33.6 m [95% CI, +9.4 to +57.7]; Hochberg-adjusted P = .02).

104 e walk distance at 6-month follow-up by 42.6 m ([90% CI, +22.2 to +infinity] P=0.005) at 2.5 hours af

105 dually increased reaching pre-PH levels at 6 m (0.3 +/- 0.01).

106 Six-minute walk distance improved by 60 m (p < 0.01), and Kansas City Cardiomyopathy Questionnai

107 n those who lived within 300 m; from 301-600 m (OR = 0.7; 95% CI 0.5-0.9) and from 601-900 m (OR = 0.

108 00 ft) and more than 50% of those above 6000 m (19700 ft).

109 rence in mean change from baseline was -16.7 m (95% CI, -47.4 to 13.9).

110 m (68.1) for the pirfenidone group and -26.7 m (79.3) for the placebo group.

111 re than GM-CSF alone (mean difference, +28.7 m [95% CI, +5.1 to +52.3]; Hochberg-adjusted P = .052).

112 6MWD fell by 29.7 m (SD, 82.9 m) more among those who died than among surv

113 The mean length of the white sharks was 3.7 m (SD +/- 0.6; total length), although the majority of t

114 9.9 to 8.4]; mean difference at 6 weeks 35.7 m [95% CI 10.5 to 60.9]; p=0.005).

115 CI -18.2 to 4.9) for losmapimod 2.5 mg, -4.7 m (-16.1 to 6.8) for losmapimod 7.5 mg, and -3.4 m (-15.

116 e in 6MWD from baseline to week 48 was -47.7 m (SE 9.3) for ataluren-treated patients and -60.7 m (9.

117 min walk distance was not significant: -6.7 m (95% CI -18.2 to 4.9) for losmapimod 2.5 mg, -4.7 m (-

118 9.3) for ataluren-treated patients and -60.7 m (9.3) for placebo-treated patients (difference 13.0 m

119 acebo in the prespecified subgroups was -7.7 m (SE 24.1, 95% CI -54.9 to 39.5; p=0.749) in the group

120 : 86.3, 95.1) and less than or equal to 5.70 m .sec(-1) at sagittal SWE (sensitivity, 41.7%; 95% CI:

121 , and accuracy using a GFR of 75 mL/min/1.73 m (eSCr75-MDRD) or the median GFR observed in period 1 (

122 filtration rate at month 3 < 30 mL/min/1.73 m (HR, 2.61; P = 0.011), de novo donor-specific antibody

123 lomerular filtration rate was 51 mL/min/1.73 m (interquartile range, 19-85 mL/min/1.73 m).

124 higher odds of having eGFR > 60 mL/min/1.73 m (odds ratio, 8.94, 95% CI 2.47-32.25, P = 0.001) and h

125 2 mL/min/1.73 m to 40.7 +/- 12.3 mL/min/1.73 m (P < 0.0001) at 12 months after conversion.

126 plantation, and 16.2 (10.0-39.0) mL/min/1.73 m (P = 0.009) when such treatment was not administered p

127 ance was reduced to less than 40 mL/min/1.73 m (p = 0.01).

128 splantation and 16.2 (10.0-39.0) mL/min/1.73 m (p=0.009) when such treatment was not administered pre

129 omerular filtrate rate, 0.01 mL/min per 1.73 m [-0.06 to +0.09]).

130 the 6-minute walk distance was greater by 74 m (95% CI, 47 to 100) (P<0.01 for all comparisons).

131 -mg/d vericiguat and placebo groups was -1.8 m (95% CI, -16.2 m to 12.6 m; P = .81), respectively.

132 55.8 m) for 10 mg of neladenoson group; 13.8 m (95% CI, -2.3 to 29.8 m) for 20 mg of neladenoson grou

133 f the 7,986 recorded dives occurred above 80 m (88.5%), but deep dives (>80 m, max 616 m) were also r

134 .305 m (1 foot), 0.914 m (3 feet), and 1.829 m (6 feet) from the patient's head during routine care.

135 mean velocity was less than or equal to 4.86 m .sec(-1) at axial SWE (sensitivity, 66.7%; 95% CI: 44.

136 esions (mean age (standard deviation): 12.87 m (+/-4.5), CST wiring: 9 contralateral, 9 ipsilateral,

137 ource, whereas 90% reduction was found at 88 m (maximum) depending on the direction of the pollen-rec

138 e group with a 6MWD of less than 300 m, 42.9 m (15.9, 11.8-74.0; p=0.007) in the group with a 6MWD of

139 re performed at 3.0 m (shallow test) and 7.9 m (deep test) below ground surface within distinct litho

140 m AMH levels across a set of approximately 9 m '1000 Genomes Reference Panel' imputed genetic variant

141 ession (NDR); 76% Male; mean (SD) age 10 y 9 m (3 y 9 m)].

142 (OR = 0.7; 95% CI 0.5-0.9) and from 601-900 m (OR = 0.6; 95% CI 0.4-0.8).

143 es were taken not </=0.305 m (1 foot), 0.914 m (3 feet), and 1.829 m (6 feet) from the patient's head

144 e walk test distance (mean difference, 20.93 m [CI, 5.91 to 35.95 m]), peak oxygen consumption (Vo2ma

145 52 m (Karkar Island) for upper limits and 95 m (Mt.

146 erall, the mean transmission distance was 95 m (95% CI: 77-113 m).

147 l assembly process corresponds to about 0.95(m - 1) for arrays containing m tiles.

148 y of DRR is much simpler than EMMA and about m (number of genetic variants) times simpler than that o

149 paragine, L-Aspartic Acid, L- Glutamic Acid, m- Erythritol, D-Melezitose, D-Sorbitol) triggered the f

150 rming behavior is strong evidence that Aibm (m >/= 10) building blocks can span bilayers.

151 (t)Bu, Ph, and p-NCC(6)H(4)); the analogues m-{-C(O)-C(5)H(3)N-(C(O)PMe)}(2) and m-{-C(O)-C(6)H(4)-(

152 rtex modes with topological charge m = 1 and m = 2 with a conversion efficiency as large as 60%.

153 e resonances to be assigned to the m = 3 and m = 4 Fabry-Perot modes.

154 ary of (3,4,5)nG1-m-PBI with n = 12 to 6 and m = 1 are reported.

155 ility indices m = 14 for the low-density and m = 20-25 for the high-density liquid.

156 robust correlation between protein size and m (FA+pH) We then measured the solubilization of fibrils

157 alogues m-{-C(O)-C(5)H(3)N-(C(O)PMe)}(2) and m-{-C(O)-C(6)H(4)-(C(O)PPh)}(2) are similarly obtained i

158 aining the p-(pentafluorosulfanyl)phenyl and m-(pentafluorosulfanyl)phenyl groups have been character

159 the fundamental mode with topological charge m = 0 can be converted to plasmon vortex modes with topo

160 plasmon vortex modes with topological charge m = 1 and m = 2 with a conversion efficiency as large as

161 h an unprecedented cooperativity coefficient m = 3.37.

162 allyl cation and [1,m]-amphoteric compounds (m = 3,4) is presented.

163 large survival differences were considered (m = 20), the Delta(m) was positive (Delta[20] = 8.9%; 95

164 d in primary muscle cells derived from Cpt1b(m-/-) mice.

165 ids in skeletal muscle is repressed in Cpt1b(m-/-) mice, strongly supporting the hypothesis that mito

166 -signalling pathways were decreased in Cpt1b(m-/-) muscle.

167 r, was increased in skeletal muscle of Cpt1b(m-/-) mice.

168 s decreased in white adipose tissue of Cpt1b(m-/-) mice.

169 cally distinct clusters on the surface, (Cu) m ,(Ag) n |polymer|glassy carbon electrode (GCE), as sho

170 Cl}(2)) affords the diphosphametacyclophanes m-{-C(O)-C(6)H(3)-5-R'-(C(O)PMe)}(2) (R' = I, Me, (t)Bu,

171 g a self-interaction cross section sigma(DM)/m < 0.47 cm(2)/g (95% CL) and disfavoring some proposed

172 its self-interaction cross section sigma(DM)/m < 1.25 square centimeters per gram (cm(2)/g) [68% conf

173 over a wide range of modulation frequency, f m = 150 MHz-1 GHz.

174 For m = 1 we find that the critical point t(c) = 1 which is

175 or m = 4, 2.74 eV for m = 3, and 2.93 eV for m = 2).

176 r blue-shift (2.53 eV for m = 4, 2.74 eV for m = 3, and 2.93 eV for m = 2).

177 have an even greater blue-shift (2.53 eV for m = 4, 2.74 eV for m = 3, and 2.93 eV for m = 2).

178 ical exponents nu, alpha, beta and gamma for m > 1 are found to be independent not only of the value

179 However, for m > 1 we find that t(c) decreases with increasing m and

180 The lamellar crystals self-organized from m = 1 and the two highly ordered columnar hexagonal peri

181 le masses and charges span a wide range from m ~ 2 to ~90 MDa and z ~ 50 to ~1300 e (elementary charg

182 tates generates a higher transconductance (g m ) and unity current gain cut-off frequency (f T ) than

183 polypropylene (PP) heavyweight meshes >50 g/m (HWM), regular lightweight PP meshes <50 g/m (regular

184 m (HWM), regular lightweight PP meshes <50 g/m (regular LWM-PP), lightweight PP mesh with absorbable

185 We tested how this Gabrb3 m-/p+ mutation affects CbN physiology in mice, separatin

186 5O68.(H2O)m]n (1, X = Si, m = 35; 2, X = Ge, m = 41), and the molecular tetramer Na6[{Na(mu-OH2)(OH2)

187 k resonators consistently display gyroscopic m = 3 modes with Q-factors above 2 Million (M) at 6.29 M

188 ne Cftr KO mice, producing hCFTR+/mCftr- (H+/m-) mice, which had normal survival, growth and goblet c

189 Holding m = 1, spectroscopy reveals that the n = 1 superlattice

190 d formation conditions attributed to h-, i-, m-, and n-nanodiamond polymorphs has resulted in their r

191 es of water and to extract fragility indices m = 14 for the low-density and m = 20-25 for the high-de

192 increases in V max (enzyme production) and K m (indicative of competitive inhibition).

193 ompetitive inhibition (decreased V max and K m ) occurred in surface peat explained by variation in h

194 m = 0.56 microM(-1)s(-1)) than NPP (k cat /K m = 0.044 microM(-1)s(-1)).

195 e was over ten fold higher for GPP (k cat /K m = 0.56 microM(-1)s(-1)) than NPP (k cat /K m = 0.044 m

196 erence (95% confidence interval, CI) -3.1 kg/m (-4.4 to -1.9) kg/m, P < 0.001] and HbA1c change [mean

197 ery, the preoperative BMI of 32.8 +/- 2.1 kg/m (mean +/- standard deviation) dropped to 25.6 +/- 2.5

198 mean body mass index loss of -7.8 +/- 5.1 kg/m (total weight loss: 16.8% +/- 9.7%) was associated wit

199 HR, 1.04; P < 0.001), body mass index <21 kg/m (aHR, 1.61; P = 0.006), and HCV (aHR, 1.83; P < 0.001)

200 (aHR,1.04; P<0.001), body mass index <21 kg/m (aHR,1.61; P=0.006), and HCV (aHR,1.83; P<0.001) were

201 atients by body mass index category: < 25 kg/m (54 patients, 18%), >= 25 kg/m to < 30 kg/m (124 patie

202 raft failure in RTR with BMI less than 25 kg/m (hazard ratio [HR], 0.64 [0.28-1.50] and 0.27 [0.09-0.

203 30 kg/m or more with BMI of less than 25 kg/m (OR: 1.6, CI: 0.8-3.5), ever smokers with never smoker

204 atients with body mass index less than 25 kg/m (p = 0.004) and for body mass index greater than or eq

205 dy mass index greater than or equal to 25 kg/m (p = 0.023).

206 /m (54 patients, 18%), >= 25 kg/m to < 30 kg/m (124 patients, 41%), >= 30 kg/m to < 35 kg/m (58 patie

207 m (124 patients, 41%), >= 30 kg/m to < 35 kg/m (58 patients, 19%), and >= 35 kg/m (69 patients, 23%).

208 o < 35 kg/m (58 patients, 19%), and >= 35 kg/m (69 patients, 23%).

209 ge was 58, with mean body mass index 34.4 kg/m (range 20-65).

210 e of a 35-year-old woman with a BMI of 42 kg/m (96.8 kg) and ESRD, who underwent combined robot-assis

211 andard deviation) dropped to 25.6 +/- 2.5 kg/m (P < 0.001).

212 recommended for patients with BMI >/= 50 kg/m (grade C), current smokers (grade A), or patients with

213 Mean initial body mass index was 50.9 kg/m [95% confidence interval (CI), 49.6-52.2].

214 a perovskite at the single-unit-cell level (m = 1).

215 series of intermediate clusters of LinBnHm (m </= 4n).

216 )n, and Li2BnHn; off-stoichiometric LinBnHm (m </= 4n) clusters were considered for n = 2, 3, and 6.

217 sters Al(n)Mg(m)(-) (4 </= n+m </= 15; 0 </= m </= 3).

218 nds of ([SnSe]1+delta)m(NbSe2)n, where 1 </= m = n </= 20, with the same atomic composition but diffe

219 onsistent with an effective mass ratio of m*/m = 0.067, the standard value, even in these high mobili

220 can minks with Moyle (m/m) and Violet (a/a m/m /p/p) phenotypes.

221 m/s for functionalized molecules with a mass m = 10,000 Da.

222 e (c-) terminated structures over the metal (m-) terminated structures for both homo and heterobilaye

223 contains mixtures of s-SWCNTs and metallic- (m-) SWCNTs with wide diameter distributions, typically i

224 Birch reductive alkylation of methyl m-(hydroxymethyl)benzoate derivatives, using lithium in

225 before and after transfusion were -0.0 L/min/m (-0.1 to 0.1 L/min/m) (p = 0.86) for cardiac index; -1

226 6% (10% to 30%), cardiac index was 1.3 L/min/m (0.7-2.2 ) and systemic resistance vascular index was

227 x went from 3.6 +/- 0.4 to 2.9 +/- 0.6 L/min/m (p = 0.01).

228 ization (2.21 L/min [+/- 0.97] and 1.2 L/min/m [+/- 0.52]).

229 vs 3.7 L/min/m; p = 0.043; bias, 0.51 L/min/m [-0.53, 1.55 L/min/m]; bias percentage, 12.7%).

230 vs 3.3 L/min/m; p < 0.0001; bias, 1.24 L/min/m [0.27, 2.22 L/min/m]; bias percentage, 31%).

231 for oxygen extraction ratio; and 4.9 mL/min/m (0.9-9.0 mL/min/m) (p = 0.02) for oxygen consumption i

232 x in the patients with sepsis was 8.4 mL/min/m (2.3-14.5 mL/min/m; p = 0.01).

233 /min) (p = 0.06) for heart rate; 96.8 mL/min/m (71.1-122.5 mL/min/m) (p < 0.01) for oxygen delivery i

234 Our studies on Co6Te8(PEt3)m(CO)n (m + n = 6) clusters show that Co6Te8(PEt3)6 has a closed

235 leading to the creation of a W state of n + m - 2 electrons in the successful case.

236 alloy metal clusters Al(n)Mg(m)(-) (4 </= n+m </= 15; 0 </= m </= 3).

237 series of Pb(m)Sb(2n)Se(m+3n) nanocrystals (m = 2, 4, 6 and 8; n = 1) are demonstrated that exist on

238 tude planetary waves with zonal wave numbers m = 6, 7, and 8.

239 Those patterns--with zonal wave numbers m = 6, 7, or 8--are characteristic of the above extremes

240 Time complexity of each iteration is O(m (3) k) for an m x k SNP matrix where m and k are the n

241 uding pyrazolyl-substituted anilines and o-, m-, and p-phenylenediamine as pi-conjugated spacers.

242 chloro-, nitro- dichloro-, and dinitro- (o-, m-, and p-) benzene guests.

243 or benzamide bonds were prepared (i.e., o-, m-, p-poly-1 and poly-2 series) and characterized both i

244 Three disubstituted benzene isomers ( o-, m-, and p-fluorophenyl piperazine) containing the diamin

245 The Suzuki-Miyaura couplings of o-, m-, and p-halophenols with o-, m-, and p-phenol boronic

246 Structures and energetics of o-, m-, and p-quinonimide anions (OC6H4N(-)) and quinoniminy

247 is varied systematically using a pair of o-, m-, or p-xylylene (o-, m-, or p-Xy) covalent linkers to

248 plings of o-, m-, and p-halophenols with o-, m-, and p-phenol boronic acids were investigated for all

249 y using a pair of o-, m-, or p-xylylene (o-, m-, or p-Xy) covalent linkers to produce o-ExBox(4+) (3.

250 rdered columnar hexagonal periodic arrays of m = 3 are assembled via thermodynamically controlled pro

251 the free energy of unfolding with a slope of m (FA+pH) (the combined contribution of FA and FA-induce

252 of 1.217(6) nm as a function of one unit of m = n was observed.

253 ctinyl peroxide cage cluster, Li48+m K12 (OH)m [UO2 (O2 )(OH)]60 (H2 O)n (m approximately 20 and n ap

254 excessive fibrosis in a heart via oncostatin-m (OSM) secretion.

255 e other ring, where X = o-MeO or p-alkyl, or m- or p-EWG; e.g., 4-methoxy-4'-trifluoromethylstilbene)

256 annealed at 500 degrees C, the higher order m = n compounds were found to convert to the thermodynam

257 ted that the muscarinic agonist oxotremorine-m (oxo-m) blocks the induction of presynaptic long-term

258 and belongs to the tetragonal space group P4/m (no.

259 approximately 0.48 forms in space group P42/m (a = 8.718(3)A, c = 6.719(2)A; Z = 2) with a new stuff

260 Diabetic and control animals received PEA-m (10 mg/kg) by oral gavage daily starting 2 wk from STZ

261 ses of P. subcapitata exposed to high purity m- and s-SWCNT fractions.

262 91.72 mg/g, Q(m (GOTW)) = 111.61 mg/g and Q(m (rGO/Fe3O4/TW)) = 104.95 mg/g) and removal rates (~99%

263 3)O(4)/TW show high adsorption capacities (Q(m (TW)) = 91.72 mg/g, Q(m (GOTW)) = 111.61 mg/g and Q(m

264 rption capacities (Q(m (TW)) = 91.72 mg/g, Q(m (GOTW)) = 111.61 mg/g and Q(m (rGO/Fe3O4/TW)) = 104.95

265 nd the intrinsic rate of natural increase (r m ) was higher on well-fertilized than under-fertilized

266 fference was considered clinically relevant (m = 0 months).

267 ger than 20 months were considered relevant (m = 20), the net chance of a longer survival was very cl

268 man body conditions (conductivity = 0.0265 S/m - 1.027 S/m, pH = 6.6-7.4, and glucose concentration =

269 Conductivities as high as 5x10(6) S/m (12% of bulk Au) were attained after sintering was con

270 rks, [Na7X2W18Sn9Cl5O68.(H2O)m]n (1, X = Si, m = 35; 2, X = Ge, m = 41), and the molecular tetramer N

271 Dual element isotope slopes m = Deltadelta(13)C/ Deltadelta(37)Cl approximately epsi

272 polymer such as Au10(SR)10 to larger Aun(SR)m (n > m) clusters that have only the staple motifs and

273 esulting in thermal destabilization (Delta T m - 10 degrees C per lesion).

274 The m = 2 dark mode does not produce a sEEG response, howeve

275 tices and the charge-ordering pattern in the m = 3 member.

276 The nanorod length is varied such that the m = 1, 2, and 3 LSPR modes are resonant with the laser e

277 Z-pinch, which is generally unstable to the m = 1 kink instability.

278 d allow the resonances to be assigned to the m = 3 and m = 4 Fabry-Perot modes.

279 he fourth cysteine can appear in any of the (m + n + o + p) randomized amino acid positions (X).

280 e groups of the NBI via one, two, and three (m = 1, 2, 3) methylenic units.

281 y reduces the addressing lines from m x n to m + n.

282 medial and the lateral antennal lobe tracts (m- and l-ALT), separately arborizing two antennal lobe h

283 bal deletion of maternal Ube3a allele; Ube3a(m-/p+)).

284 In Ube3a knockdown cell lines and UBE3A(m-/p+) cortical neurons, the GA is severely under-acidif

285 l cortex of control and AS model mice (Ube3a(m-/p+) mice).

286 e we extend evidence in AS model mice (Ube3a(m-/p+)) of paternal UBE3A expression within the suprachi

287 inates UBE3A protein from the brain of Ube3a(m-/p+) mice, because the paternal allele is epigenetical

288 was enhanced in hippocampal slices of Ube3A(m-/p+) mice, which model AS.

289 Specifically, Ube3a(m-/p+) mice have a markedly reduced capacity to accumula

290 in a mouse model of Angelman syndrome (Ube3a(m-/p+) mice).

291 We found that while Ube3a(m-/p+) mice maintained relatively normal circadian rhyth

292 s linearly with pressure and reaches 59.2 W/(m .

293 of pristine MgSiO3 pv is found to be 10.7 W/(m .

294 on (cAS, in mol kg(-1) aerosol liquid water, m = molality) and sulfate ionic strength, I(SO4(2-)) (m)

295 ~ H(n) with n = 0.603(6) and RCP ~ H(m) with m = 1.20(1) when H//c.

296 orinated groups and the dendronized NBI with m = 1 and 2 self-organize into lamellar crystals.

297 The dendronized NBI with m = 3 self-assembles into an unprecedentedly complex and

298 , and single-layered Dion-Jacobson type with m = 2 and A = BDA, M(I) = Ag, M(III)= In or Bi, X = Cl o

299 (single-layered Ruddlesden-Popper type with m = 4 and A = PA or OCA, and single-layered Dion-Jacobso

300 This allows the generation of 3 x (m + n + o + p) different peptide topologies because the